Article
Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).
Leukemia & lymphoma - 1 Feb 2018
Sanikommu Srinivasa R, Clemente Michael J, Chomczynski Peter, Afable Manuel G, Jerez Andres, Thota Swapna, Patel Bhumika, Hirsch Cassandra, Nazha Aziz, Desamito John, Lichtin Alan, Pohlman Brad, Sekeres Mikkael A, Radivoyevitch Tomas, Maciejewski Jaroslaw P
Abstract excerpt
Large granular lymphocytic leukemia (LGLL) represents a clonal/oligoclonal lymphoproliferation of cytotoxic T and natural killer cells often associated with STAT3 mutations. When symptomatic, due to mostly anemia and neutropenia, therapy choices are often empirically-based, because only few clinical trials and systematic studies have been performed. Incorporating new molecular and flow cytometry parameters, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
